middl
east
respiratori
syndrom
coronaviru
merscov
novel
human
viru
emerg
caus
signific
respiratori
diseas
kindl
fear
sarslik
epidem
travers
world
hilgenfeld
peiri
lack
rapid
humantohuman
spread
seen
sarscov
cousin
outbreak
merscov
continu
middl
east
past
three
year
lead
infect
countri
case
death
period
reintroduct
zoonot
sourc
possibl
human
adapt
merscov
remain
signific
global
public
health
threat
highlight
need
therapeut
countermeasur
limit
infect
spread
despit
sever
year
studi
understand
merscov
infect
limit
varieti
factor
includ
difficulti
access
sampl
limit
autopsi
data
lack
robust
anim
model
diseas
zumla
et
al
howev
number
report
provid
insight
tool
studi
includ
extens
sequenc
data
revers
genet
resourc
monoclon
antibodi
treatment
infect
zumla
et
al
contrast
vaccin
strategi
limit
due
absenc
robust
anim
model
typic
examin
mice
presenc
specif
charg
glycosyl
differ
human
rodent
receptor
merscov
prevent
infect
peck
et
al
therefor
tradit
approach
studi
pathogenesi
vaccin
efficaci
stunt
lack
small
anim
model
shift
merscov
research
larger
vivo
model
includ
nonhuman
primat
ungul
van
doremalen
munster
koch
postul
first
achiev
merscov
rhesu
macaqu
falzarano
et
al
subsequ
larg
anim
model
report
includ
marmoset
camel
rabbit
alpaca
vari
level
merscov
pathogenesi
van
doremalen
munster
new
small
anim
model
describ
continu
develop
short
term
nonhuman
primat
provid
best
model
test
vaccin
therapeut
issu
ebiomedicin
lan
colleagu
describ
vaccin
studi
nonhuman
primat
model
merscov
infect
lan
et
al
build
previou
studi
rhesu
macaqu
sarscov
wang
et
al
report
detail
efficaci
mer
vaccin
base
recombin
receptor
bind
domain
rbd
subunit
result
indic
stimul
humor
cellular
immun
follow
vaccin
boost
subsequ
intratrach
challeng
vaccin
monkey
reveal
partial
protect
merscov
induc
pathogenesi
includ
reduc
pneumonia
viral
titer
test
sar
merscov
platform
potenti
rapid
respons
vaccin
approach
futur
emerg
cov
outbreak
similarli
platform
could
also
deploy
reservoir
popul
like
camel
thought
harbor
viru
zumla
et
al
howev
rbdbase
vaccin
fail
produc
steril
immun
typic
sought
context
vaccin
overal
result
demonstr
rhesu
macaqu
model
subunit
vaccin
target
receptorbind
domain
merscov
offer
level
protect
requir
refin
induc
steril
immun
studi
show
promis
receptor
bind
domainbas
vaccin
platform
number
question
remain
rhesu
macaqu
model
support
merscov
replic
fail
recapitul
sever
diseas
seen
human
level
protect
studi
may
underestim
util
approach
altern
provid
minor
protect
human
diseas
studi
pathogen
model
like
marmoset
adapt
virus
requir
deciph
question
similarli
rbdbase
platform
drive
protect
aspect
vaccin
efficaci
test
macaqu
model
previou
work
doubl
inactiv
sarscov
shown
efficaci
young
mice
spruth
et
al
howev
subsequ
analysi
age
anim
heterolog
challeng
reveal
vaccin
failur
signific
immun
patholog
boll
et
al
test
experiment
system
base
report
case
age
immunocompromis
statu
appear
comorbid
factor
merscov
infect
lethal
hilgenfeld
peiri
zumla
et
al
therefor
test
efficaci
vaccin
age
immun
compromis
popul
must
consid
addit
continu
reintroduct
merscov
zoonot
sourc
increas
likelihood
exposur
heterolog
viru
focu
vaccin
rbd
mer
possibl
vaccineinduc
immun
patholog
reduc
howev
vivo
test
requir
confirm
result
overal
report
lan
colleagu
detail
promis
mersrbdbas
platform
vaccin
develop
combin
strong
neutral
reduc
pathogenesi
rhesu
macaqu
indic
approach
worth
pursu
howev
addit
studi
requir
model
captur
pathogenesi
seen
human
efficaci
age
popul
possibl
immun
patholog
due
heterolog
challeng
despit
caveat
success
rbdbase
approach
import
implic
mer
treatment
well
rapid
vaccin
develop
platform
futur
emerg
cov
outbreak
